There are significant health care disparities in overdose recovery resources, emphasizing the need for better connections ...

While observational studies have previously pointed to an association, being able to identify causation has been difficult due to overlapping risk factors and confounding variables.

Chris Johnson, MBA, emphasizes that the constantly shifting landscape of Medicaid could further confuse both patients and health care providers, potentially leaving children behind.

Patients with chronic obstructive pulmonary disease (COPD) who smoke were less likely to receive tobacco dependence treatment (TDT) if they lived in rural areas or had longer travel times to care, ...

A single-center study comparing patients with chronic lymphocytic leukemia receiving venetoclax as part of a clinical trial ...

The FDA has approved rilzabrutinib (Wayrilz; Sanofi) as a groundbreaking treatment for immune thrombocytopenia (ITP), enhancing patient outcomes and quality of life.

Cutting-edge therapies can help move the treatment landscape forward, but basic treatment and prevention, such as smoking ...

A global analysis showed that absolute deaths and disability-adjusted life-years related to smoking-attributable rheumatoid arthritis have continued to rise since 1990.

Medical school application and matriculation rates decreased for underrepresented racial and ethnic minorities in medicine ...

The FDA has broadened the indication for evolocumab (Repatha; Amgen) to include adults at increased risk of major adverse ...

In an observational extension of the myPACE clinical trial, researchers found that a personalized accelerated pacing in ...

The FDA has approved an updated COVID-19 booster while limiting access to high-risk individuals, amid ongoing debates on ...